CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

EUDRAGIT® for Controlled Release Oral Drugs

EUDRAGIT® for Controlled Release Oral Drugs

Product Description

Poly(meth)acrylates for controlled-, immediate- and delayed-release oral solid dosage forms. Get in contact with us for customized polymers.

Evonik Corp

Country/Region:

United States
On CPHI since:

2017
Certificates:

1

Company types

Manufacturer/Innovator

Compare Add to favorites Added to favorites

Categories

Sales Markets

Middle East Region (e.g. UAE)
Oceania
North America (USA, Canada)
Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

Evonik Corp

Country/Region:

United States
On CPHI since:

2017
Certificates:

1

Company types

Manufacturer/Innovator

Compare Add to favorites Added to favorites

More Products from Evonik Corp (2)

Product Specialized Parenteral Drug Services

Meeting the parenteral drug delivery challenge with Evonik. Polymer-based parenteral formulations taking extended release and targeted release further – advanced parenterals from small molecules to biopharmaceuticals - all bases covered. Lipid nanoparticle drug delivery technologies for oligon...

Compare
Product Exclusive Synthesis of APIs and Intermediates

Proprietary and custom advanced intermediates and APIs. CMO for APIs from the clinical stage through commercialization. Specific expertise in highly potent active pharmaceutical ingredients (HPAPIs), microbial fermentation, continuous processing and more.

Compare